Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis

Condition:   Desmoid TumorInterventions:   Drug: sorafenib tosylate;   Other: placebo;   Other: laboratory biomarker analysis;   Other: quality-of-life assessmentSponsor:   National Cancer Institute (NCI)Recruiting - verified September 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials